TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 68 filers reported holding TRINITY BIOTECH PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | -50.0% | 300 | +100.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | -94.6% | 150 | -95.3% | 0.00% | -100.0% |
| Q4 2015 | $37,000 | -14.0% | 3,202 | -11.8% | 0.00% | 0.0% |
| Q3 2015 | $43,000 | +290.9% | 3,632 | +500.3% | 0.00% | – |
| Q2 2015 | $11,000 | -8.3% | 605 | -5.6% | 0.00% | – |
| Q1 2015 | $12,000 | -14.3% | 641 | -20.4% | 0.00% | – |
| Q4 2014 | $14,000 | -84.1% | 805 | -83.2% | 0.00% | -100.0% |
| Q3 2014 | $88,000 | -22.1% | 4,805 | -1.7% | 0.00% | -33.3% |
| Q2 2014 | $113,000 | -15.0% | 4,890 | -11.2% | 0.00% | -25.0% |
| Q1 2014 | $133,000 | -4.3% | 5,504 | -0.5% | 0.00% | 0.0% |
| Q4 2013 | $139,000 | +18.8% | 5,531 | +3.3% | 0.00% | 0.0% |
| Q3 2013 | $117,000 | +41.0% | 5,354 | +9.2% | 0.00% | +33.3% |
| Q2 2013 | $83,000 | – | 4,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 815,041 | $15,690,000 | 4.96% |
| Lyon Street Capital, LLC | 570,387 | $10,980,000 | 4.73% |
| Centaur Capital | 135,000 | $2,599,000 | 3.61% |
| GOLDMAN CAPITAL MANAGEMENT INC | 309,690 | $5,962,000 | 3.48% |
| Paradice Investment Management LLC | 584,024 | $11,242,000 | 2.36% |
| RK Capital | 601,672 | $11,582,000 | 2.31% |
| Park West Asset Management LLC | 673,079 | $12,957,000 | 1.89% |
| KEANE CAPITAL MANAGEMENT INC | 95,259 | $1,834,000 | 1.79% |
| Adirondack Research & Management Inc. | 227,052 | $4,371,000 | 1.70% |
| Benchmark Capital Advisors | 92,441 | $1,779,000 | 1.17% |